Free Trial
NYSE:TFX

Teleflex Q3 2026 Earnings Date & Estimates

Teleflex logo
$124.36 -0.12 (-0.10%)
Closing price 10/8/2026 03:59 PM Eastern
Extended Trading
$124.19 -0.17 (-0.14%)
As of 06:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Teleflex is expected to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens

What Analysts Expect from Teleflex in Q3 2026

Teleflex is expected to post earnings of $1.90 per share on revenue of $565.37 million. In the same quarter a year earlier Teleflex reported $3.67 per share on revenue of $892.90 million. Teleflex last reported on August 6, 2026, posting $1.76 per share and beating the $1.28 consensus estimate. Teleflex has beaten the consensus EPS estimate in 7 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$1.90
Expected Revenue
$565.37 million
Prior-Year EPS
$3.67
Prior-Year Revenue
$892.90 million
Expected EPS Growth
-48.2%
Expected Revenue Growth
-36.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$1.76 (Beat by +$0.48)
Last Quarter Revenue
$570.33 million
EPS Beat Rate
7 of last 8 quarters

Teleflex Q3 2026 Earnings FAQ

Teleflex (NYSE:TFX) is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Teleflex's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Teleflex to post earnings of $1.90 per share for Q3 2026.

The consensus revenue estimate for Teleflex is $565.37 million for Q3 2026.

Teleflex Earnings Headlines

RBC Capital Reaffirms Their Buy Rating on Teleflex (TFX)
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
See More Teleflex Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Teleflex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teleflex and other key companies, straight to your email.

About Teleflex

Teleflex (NYSE:TFX) is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, physicians and other healthcare providers. Its products are designed to support minimally invasive procedures, critical care and a range of clinical applications.

The company’s portfolio includes devices for vascular access and intervention, anesthesia, respiratory care, emergency medicine, surgery, urology and pain management. Teleflex markets products under brands including Arrow, which is known for vascular access and catheter-based technologies, as well as other specialized product lines used in hospitals and outpatient settings.

Teleflex serves healthcare markets in North America, Europe, Asia and other international regions. The company traces its roots to the 1940s and has expanded its medical technology business through internal development and acquisitions, including the addition of Vascular Solutions and Z-Medica.

View Teleflex Profile